FSMAX
Price
$91.53
Change
-$4.22 (-4.41%)
Updated
Dec 18 closing price
TFGRX
Price
$43.65
Change
-$0.39 (-0.89%)
Updated
Dec 17 closing price
Ad is loading...

FSMAX vs TFGRX

Header iconFSMAX vs TFGRX Comparison
Open Charts FSMAX vs TFGRXBanner chart's image
Fidelity Extended Market Index
Price$91.53
Change-$4.22 (-4.41%)
VolumeN/A
CapitalizationN/A
Touchstone Mid Cap Growth R6
Price$43.65
Change-$0.39 (-0.89%)
VolumeN/A
CapitalizationN/A
FSMAX vs TFGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. TFGRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TFGRX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 44.5B vs. TFGRX (1.46B). FSMAX pays higher dividends than TFGRX: FSMAX (1.10) vs TFGRX (0.00). FSMAX was incepted earlier than TFGRX: FSMAX (13 years) vs TFGRX (5 years). TFGRX is a more actively managed with annual turnover of: 56.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than TFGRX: FSMAX (0) vs TFGRX (50000). FSMAX annual gain was more profitable for investors over the last year : 24.85 vs. TFGRX (20.55).
FSMAXTFGRXFSMAX / TFGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years5 years-
Gain YTD22.66218.905120%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets44.5B1.46B3,056%
Annual Yield % from dividends1.100.00-
Returns for 1 year24.8520.55121%
Returns for 3 years15.9012.18131%
Returns for 5 years54.67N/A-
Returns for 10 years88.57N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSAI13.923.72
+36.47%
Hesai Group American Depositary Share each ADS represents one
STRA99.76-1.86
-1.83%
Strategic Education
KNSL491.06-11.01
-2.19%
Kinsale Capital Group
LOOP1.60-0.14
-8.05%
Loop Industries
MBRX1.86-0.33
-15.07%
Moleculin Biotech